How did POAI's Q3 2024 earnings surprise impact investor sentiment?

Predictive Oncology (POAI) experienced a decline in investor sentiment during Q3 2024, as evidenced by the company's stock performance and earnings surprise.

1. **Earnings Surprise**: The EPS Surprise for POAI in Q3 2024 was -0.16, indicating that the company's actual earnings fell short of market expectations.

|code|Ticker|Name|Date|Revenue Surprise|EPS Surprise|market_code|
|---|---|---|---|---|---|---|
|POAI|POAI.O|Predictive Oncology|2024 Q3|-154314|-0.16|186|

2. **Investor Sentiment**: The stock's price decreased by 2.19% in the period, reflecting investor disappointment in the earnings report. While there were minor fluctuations in sentiment (e.g., a 1.77% increase on July 11, 2024, and a 1.6% increase on August 20, 2024), the overall trend was negative, with a significant low point at -5.83% on July 31, 2024.

|code|Ticker|Name|Date|Percentage Change|market_code|
|---|---|---|---|---|---|
|POAI|POAI.O|Predictive Oncology|20240701|-0.9615|186|
|POAI|POAI.O|Predictive Oncology|20240702|-0.9709|186|
|POAI|POAI.O|Predictive Oncology|20240703|-0.9804|186|
|POAI|POAI.O|Predictive Oncology|20240705|-4.1881|186|
|POAI|POAI.O|Predictive Oncology|20240708|7.4713|186|
|POAI|POAI.O|Predictive Oncology|20240709|-0.9615|186|
|POAI|POAI.O|Predictive Oncology|20240710|-3.6505|186|
|POAI|POAI.O|Predictive Oncology|20240711|1.7735|186|
|POAI|POAI.O|Predictive Oncology|20240712|10.8911|186|
|POAI|POAI.O|Predictive Oncology|20240715|-0.8929|186|

In conclusion, POAI's Q3 2024 earnings surprise had a negative impact on investor sentiment, leading to a general decline in the stock's performance and a period of low investor confidence.